Cited by 72Genetic Neurodegenerative DiseasesNeurological Disorders and TreatmentsParkinson's Disease Mechanisms and Treatments

Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum

Thangarajan, Sumathi, Deivasigamani, Asha, Natarajan, Suganya Sarumani, Krishnan, Prasanna, Mohanan, Sandhya Koombankallil·2014·International Journal of Neuroscience

Abstract

The present study has been designed to investigate the protective effect of L-theanine against 3-nitropropionic acid (3-NP)-induced Huntington's disease (HD)-like symptoms in rats. The present experimental protocol design includes systemic 3-NP acid (10 mg/kg intraperitonially) treatment for 14 d. L-theanine (100 and 200 mg/kg) was given orally, once a day, 1 h before 3-NP acid treatment for 14 d. Body weight and behavioral parameters (Morris water maze, open field test (OFT), forced swim test (FST) and rotarod activity) were assessed on 1st, 5th, 10th and 15th day post-3-NP acid administration. Malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT) levels and mitochondrial enzyme complex. Succinate dehydrogenase (SDH) were measured on the 15th day in the striatum. Systemic 3-NP acid treatment significantly reduced body weight, locomotor activity and oxidative defense. The mitochondrial enzyme activity was also significantly impaired in the striatum region in 3-NP acid-treated animals. L-theanine (100 and 200 mg/kg b.wt.) treatment significantly attenuated the impairment in behavioral, biochemical and mitochondrial enzyme activities as compared to the 3-NP acid-treated group. The results of the present study suggest that pretreatment with L-theanine significantly attenuated 3-NP induced oxidative stress and restored the decreased SOD, GSH, CAT and SDH activity. It also decreased the neuronal damage as evidenced by histopathological analysis of striatum. Based on the above study, it has been proved that L-theanine has neuroprotective activity against 3-NP induced neurotoxicity.

Integrity signals

Registry

Crossref · 10.3109/00207454.2013.872642

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies report an anxiolytic effect of a single dose of theanine up to 200-250 mg per day, and it may be extended up to 1250 mg/day.

    “Recent studies referred anxiolytic effect of single dose of theanine up to 200-250 mg per day and it may be extended up to 1 250 mg/day [9,12,[35][36][37] .”
  • Theanine protects neural damage and improves function by reducing cerebral infarction through inhibiting catalase, superoxide dismutase, and succinate dehydrogenase activity, thus reducing GSH and oxidative damage of neuronal cells.

    “Theanine helps to protect neural damage and improve function by reduction of cerebral infarction by inhibiting different neurological functions like catalase, superoxide dismutase, and succinate dehydrogenase (SDH) activity, thus reduces GSH and oxidative damage of neuronal cells [36][37][38] .”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Thangarajan, S., Deivasigamani, A., Natarajan, S. S., Krishnan, P., & Mohanan, S. K.
Affiliations
University of Madras (IN)
Venue
International Journal of Neuroscience
Published
2014-01-23
Volume
124
Issue
9
Pages
673-684
ISSN
  • 0020-7454 (ISSN-L)
  • 1543-5245
OpenAlex
W2107972568
Cited by
71
References
54
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 8 · 2022: 7 · 2021: 2 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 10 · 2015: 7 · 2014: 2
FWCI
3.11
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
theanine, neuroprotection, 3-nitropropionic acid, Huntington's disease model, striatum, oxidative stress, mitochondrial dysfunction, succinate dehydrogenase, antioxidant enzymes, locomotor impairment, neurotoxicity
MeSH terms
Animals, Body Weight, Brain, Catalase, Convulsants, Corpus Striatum, Exploratory Behavior, Glutamates, Glutathione, Male, Mitochondria, Motor Activity, Nitro Compounds, Propionates, Superoxide Dismutase, Lipid Peroxidation, Rats, Wistar, Neuroprotective Agents, Maze Learning, Neurotoxicity Syndromes, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review